Muscle Relaxant Drugs Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Muscle Relaxant Drugs Market in 2025 is estimated at USD 3.62 million. The global market size was estimated at over USD 3.43 million in 2024 and is anticipated to grow at a CAGR of 6.9%, with projections indicating it will exceed USD 8.17 million by 2037. North America is anticipated to secure the top share, attributed to healthcare spending growth, low physical activity, and high prevalence of musculoskeletal conditions.
The market growth can be ascribed to rising number of populations suffering from musculoskeletal conditions worldwide, along with patients with lower back pain. As per recent statistics provided by the Global Burden of Disease (GBD) in the year 2019, more than 1.71 billion people live with musculoskeletal conditions around the globe. A common problem noticed worldwide is deteriorating muscle health and an increase in muscle spasms. An upsurge in problems such as muscle cramps, sprains and strains, fibromyalgia, tendinitis, neuromuscular disorders, and many more diseases has been observed worldwide.
